The evaluation of the effect of IGF2BP3 on AKT/mTOR signalling in NPC cells by Western blot analysis indicated that silencing of IGF2BP3 reduced the phosphorylation of AKT and mTOR (Figure 5A and B). Here, IGF2BP3 is linked to nasopharyngeal carcinoma.